PROVENT trial (PRJCA032503)
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/DRP014123
下载链接
链接失效反馈官方服务：
资源简介：
This cohort consists of raw 16s sequencing data from 89 post-rectal examination urine samples of male patients aged >16 years old with a histological diagnosis of prostate cancer with Gleason grade 6 or 7 and no previous treatment for prostate cancer. These patients were recruited to PROVENT (ClinicalTrials.gov ID: NCT03103152), a phase 2 placebo-controlled trial of two doses of aspirin (100 and 300mg) and one dose of Vitamin D (4,000 IU in nasal drops daily).
创建时间：
2025-11-19
